CDPH-CTCA Joint Guidance and Related Guidelines
The California Department of Public Health (CDPH) Tuberculosis Control Branch (TBCB) and CTCA Joint Guidelines and Fact Sheets below are developed by representatives from the state and local health department TB control programs as needed. CTCA member and CDPH-TBCB have endorsed these guidelines for use in California. These guidelines do not cover every aspect of TB control. Clinicians should refer to national guidelines for subject areas not included below. Modifying this guidance for local use requires the removal of logos and footers, and acknowledging the source document/s. Guidance not being reviewed and updated, due to resource limitations, are posted on the Additional Resources tab.
Diagnosis and Treatment
- NEW! Preventing TB Disease in 4 Steps, January 2024
-
Actions and Best Practices for Diagnosis and Treatment of Tuberculosis (TB) and Latent TB Infection (LTBI), Rev February 2023
- Latent Tuberculosis Infection Guidance for Preventing Tuberculosis In California, revised June 2019 is retired. Clinical trial-based guidance from CDC is available and linked here: Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, Feb. 14, 2020
LTBI: A Guide for Primary Health Care Providers, July 2020 - The CDPH CTCA California Adult TB Risk Assessment, 2024 is linked here: https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/TB-Risk-Assessment.aspx
- Supplement to the ATS/CDC/IDSA 2016 Guidelines for the Treatment of Drug Susceptible Tuberculosis, 2019
The ATS/CDC/IDSA 2016 TB Treatment Guidelines are also linked on the CDC Guidelines page of this website.
TB treatment regimens, including the new short course treatment: https://www.cdc.gov/tb/topic/treatment/tbdisease.htm - Follow-Up and Assessment of Persons with Class A/B Tuberculosis, revised 2015 (under revision)